hD
$
4.45
6.12%
-$0.29
As of October 16, 2026
· USD
Open
$4.73
High
$4.74
Low
$4.44
Prev Close
$4.74
Volume
2.23M
52-Wk High
$7.01
52-Wk Low
$3.5
Market Cap
$914.30M
P/E
-7.95
EPS
$-0.56
About
Savara Inc. is a biopharmaceutical firm in the clinical development phase, specializing in therapies for uncommon respiratory conditions. Their primary investigational drug, molgramostim, is an inhaled form of granulocyt...See more
Ticker
SVRA
Exchange
NASDAQ Global Select
Industry
Biotechnology
Sector
Healthcare
CEO
Matthew Pauls
Website
https://www.savarapharma.com ↗
Address
The Tannery, Yardley, PA, 19067, US
Phone
512 614 1848
Market Cap
$914.30M
Financial Performance
| Net sales | |||||
| Gross margin | |||||
| Net income |
In the news